Nanoparticle Vaccines Based on the Truncated VZV gE Elicit a Robust Immune Response in Mice. [PDF]
Shi T +13 more
europepmc +1 more source
Transient Increased Risk of Shingles Post-Shingrix Vaccination: Self-Controlled Case-Series Analysis. [PDF]
Shetty AN +5 more
europepmc +1 more source
Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization. [PDF]
Martino EA +10 more
europepmc +1 more source
Challenges and recommendations of vaccination in immunosuppression. [PDF]
Martins CAO +3 more
europepmc +1 more source
Varicella-Zoster Virus Infection and Varicella-Zoster Virus Vaccine-Related Ocular Complications. [PDF]
Yu J, Li H, Ji Y, Liao H.
europepmc +1 more source
Effectiveness and safety of the recombinant zoster vaccine in adults aged ≥50 years with inflammatory bowel disease. [PDF]
Tseng HF +17 more
europepmc +1 more source
Vaccination in Children with Chronic Kidney Disease: Current Status and Perspectives. [PDF]
Bitsori M, Michailou M, Galanakis E.
europepmc +1 more source
Lichen planus following recombinant zoster vaccine. [PDF]
Gruen CC, Coffel BN, Hahn P.
europepmc +1 more source
Herpes Zoster in Children in the Post-Vaccination Era: Age Shift, Clinical Characteristics, and Changing Dermatomal Patterns. [PDF]
Sepetci MS, Cosansu NC, Solak B.
europepmc +1 more source

